The role of mTOR and cross-talk with inflammatory and sympathetic systems and insulin signaling are very new and interesting observations and deserve further study to understand the molecular pathophysiology responsible for the increased cardiovascular disease associated with MetS. The gene discussed is MTOR; the disease is metabolic syndrome.